A1 milk is regular cow’s milk that contains a specific type of protein called A1 beta-casein. It’s the standard milk sold in most Western countries, produced primarily by the Holstein and Friesian cattle breeds that dominate commercial dairy farming. The “A1” label refers to one of two common variants of beta-casein, a major protein in cow’s milk. The other variant, A2, differs by just a single amino acid but behaves differently during digestion, which has sparked a growing debate about whether A1 milk contributes to digestive discomfort and other health issues.
The Single Amino Acid That Separates A1 From A2
Beta-casein is one of the most abundant proteins in cow’s milk. It exists in two main forms, A1 and A2, and the difference between them comes down to one amino acid at position 67 in the protein chain. A1 beta-casein has histidine at that spot, while A2 has proline. This tiny change is the result of a single-letter mutation in the gene’s DNA code (CAT instead of CCT).
The A2 form is the original version. All cows once produced only A2 milk. At some point, a natural mutation introduced the A1 variant, which then spread through certain cattle populations, particularly European breeds. Today, most conventional milk in the United States, Canada, Australia, and northern Europe is a mix of A1 and A2 beta-casein, with a typical ratio of about 75% A1 to 25% A2.
Which Breeds Produce A1 Milk
The prevalence of A1 or A2 protein depends heavily on the breed. Holstein cattle, the black-and-white cows responsible for the vast majority of commercial milk in North America and much of Europe, carry a high frequency of the A1 gene. Simmental cows are also commonly A1/A2 carriers, with roughly 57% carrying a mixed genotype and about 10% being pure A1.
Breeds more commonly associated with A2 milk include Jersey, Guernsey, Brown Swiss, and most Asian and African cattle breeds. Jersey cows tend to carry higher A2 frequencies, though they are not universally pure A2. Goats, sheep, buffalo, and human mothers all produce milk with only the A2 type of beta-casein, meaning A1 is essentially a trait found in certain cow breeds and no other common dairy animals.
What Happens When You Digest A1 Milk
The reason the A1/A2 distinction matters has to do with what happens in your gut. When digestive enzymes break down A1 beta-casein, they release a peptide fragment called beta-casomorphin-7, or BCM-7. The histidine at position 67 in A1 protein creates a cleavage point that enzymes can easily cut. A2 beta-casein, with its proline at the same position, resists this particular cut. A2 digestion produces mostly a different fragment (BCM-9) and only small amounts of BCM-7.
BCM-7 is classified as an opioid peptide, meaning it can interact with opioid receptors in the gut. This interaction appears to slow or alter gut motility and may trigger inflammatory responses in some people. A clinical trial using MRI imaging found that A1-containing milk moved through the stomach significantly faster than pure A2 milk in people with lactose maldigestion, with measurable differences at 10, 30, 60, and 120 minutes after drinking. Faster gastric transit can push more undigested lactose into the lower intestine, which is where fermentation by gut bacteria produces gas, bloating, and discomfort.
A1 Milk and Digestive Symptoms
The symptoms that some people experience after drinking conventional milk, including abdominal pain, bloating, flatulence, and diarrhea, are typically attributed to lactose intolerance. But a growing body of research suggests that A1 beta-casein may be responsible for at least some of that discomfort. In a randomized, double-blind crossover trial, lactose-intolerant subjects who drank milk containing only A2 beta-casein reported significantly lower abdominal pain scores compared to when they drank conventional milk containing A1. The study used a validated symptom scoring system and found a statistically significant difference (p = 0.004) for pain specifically.
This raises an interesting possibility: some people who believe they are lactose intolerant may actually be reacting to the A1 protein rather than lactose itself. Earlier studies on A1 and A2 milk sometimes selected participants based on self-reported lactose intolerance without rigorous screening, meaning some subjects may not have been truly lactose intolerant at all. The overlap in symptoms between lactose intolerance and A1 protein sensitivity (they produce the same complaints: gas, bloating, pain, loose stools) makes it difficult to tell the two apart without controlled testing. These symptoms are also distinct from a true milk allergy, which involves the immune system reacting to milk proteins and can cause hives, swelling, or anaphylaxis.
Links to Heart Disease and Type 1 Diabetes
Beyond digestive effects, some researchers have investigated whether long-term A1 milk consumption correlates with chronic diseases. A study of 20 affluent countries found that per-capita consumption of A1 beta-casein had a stronger positive correlation with heart disease mortality (r = 0.76) than traditional risk markers like saturated fat intake or atherogenic index scores. A 1% change in A1 consumption in 1990 was associated with a 0.57% change in heart disease rates five years later. On multiple regression analysis, A1 consumption was the only food supply variable that remained significantly correlated with heart disease.
The pattern for type 1 diabetes is similar. A cross-country analysis of 19 developed nations found a striking correlation (r = 0.92) between A1 beta-casein supply per capita and type 1 diabetes incidence. Finland and Sweden, which have the highest A1 consumption, also have the highest rates of type 1 diabetes, while Venezuela and Japan, where A1 consumption is very low, have among the lowest rates. Animal studies have supported this link: feeding A1 beta-casein to diabetes-prone mice increased their incidence of the disease.
These are population-level correlations, not proof of causation. Countries differ in genetics, healthcare, diet, and countless other factors. But the consistency of the pattern across different analyses has kept the hypothesis alive in research circles. The European Food Safety Authority reviewed the evidence in 2009 and concluded that while BCM-7 is indeed an opioid peptide released from A1 but not A2 milk, there was not yet convincing evidence for physiological effects in humans. Notably, that review did not examine gastrointestinal intolerance specifically, which is where much of the more recent clinical evidence has focused.
How A1 Milk Differs From What’s Labeled “A2”
When you see milk labeled “A2” in the grocery store, it comes from cows that have been genetically tested to confirm they carry two copies of the A2 gene and produce no A1 beta-casein. Standard unlabeled milk is a blend of A1 and A2 protein because most dairy herds contain a mix of genotypes. You cannot taste the difference between A1 and A2 milk; the fat content, lactose levels, calcium, and other nutrients are identical. The only difference is which version of beta-casein is present.
If you experience digestive discomfort from regular milk, switching to A2 milk for a few weeks is a straightforward way to test whether A1 protein might be a factor. If your symptoms improve, it suggests the protein rather than lactose was the issue. If symptoms persist, lactose or another component is more likely the culprit. Lactose-free milk still contains A1 beta-casein (unless specifically labeled A2), so people who remain uncomfortable on lactose-free products may want to consider the protein angle.